EVALUASI PENGGUNAAN ANTIHIPERTENSI DAN ANTIKONVULSAN PADA PASIEN PREEKLAMPSIA BERAT DAN EKLAMPSIA DI INSTALASI RAWAT INAP RS PKU MUHAMMADIYAH YOGYAKARTA PERIODE TAHUN 2011 � 2012
| Main Authors: | , LATIFAH ESTRIYANI, , Dr. Ika Puspita Sari, M.Si., Apt |
|---|---|
| Format: | Thesis NonPeerReviewed |
| Terbitan: |
[Yogyakarta] : Universitas Gadjah Mada
, 2013
|
| Subjects: | |
| Online Access: |
https://repository.ugm.ac.id/126566/ http://etd.ugm.ac.id/index.php?mod=penelitian_detail&sub=PenelitianDetail&act=view&typ=html&buku_id=66792 |
Daftar Isi:
- Morbidity and mortality from preeclampsia and eclampsia is high enough so it is necessary to evaluate the use of drugs in the treatment of preeclampsia and eclampsia. The aim of this research are to determine the patient characteristics, the pattern of the use of antihypertensive and anticonvulsant, the suitability of the use of antihypertensive and anticonvulsant, and the description of the patient condition after treatment. This research was conducted at PKU Muhammadiyah Yogyakarta Hospital with non-experimental design. Data collecting retrospectively from the medical records and processing descriptively. The suitability of the use of antihypertensive and anticonvulsant analyzed by The Society of Obstetricians and Gynaecologists of Canada (SOGC) Guideline 2008, Standards of Medical Care PKU Muhammadiyah Yogyakarta Hospital 2005, and Indonesian Society of Obstetricians and Gynecologist (POGI) Guideline 2006. The samples who met the inclusion criteria as many as 28 people. Severe preeclampsia and eclampsia were more common between the ages of 20-35 years (89,29%), nullipara women (53,57%), and diagnosed at gestational age > 37 weeks (57,14%). The most used antihypertensive therapy was nifedipine (68,18%). The most used anticonvulsant therapy was magnesium sulfate (84,62%). Average suitability of the use of antihypertensive were 79,96% right indication, 71,61% right patient, and 100% right dose. Average suitability of the use of anticonvulsant were 90,48% right indication, 79,23% right patient, and 71,92% right dose. Most length of stay > 5 days (46,43%), 92,56% of mothers recovered, 96% of infants alived, and low birth weight occured in 40% of infants.